Author
Abstract
Spinal cord injury is associated with the damage to neural circuits and disruption of neural pathways, leading to irreversible long-term complications in terms of physical and mental health. Traditional treatments mainly include surgical decompression and pharmacotherapy whereas none of them could attenuate or even alleviate long-term complications following SCI. This is largely due to complicated pathophysiological process in SCI which includes primary injury and secondary injury. Primary injury is defined as direct mechanical damage on the spinal cord in the initial time course of injury. Secondary injury occurs a few hours after primary injury and it could persist for longer time, promoting a catastrophe of degenerative pathophysiological process in spinal cord and related tissues. Although currently there is no effective cure strategies for SCI, some recent studies have shown that stem cell therapy combined with other strategies is able to enhance neurofunctional recovery and neural stem cell line is one of the stem cell lines which show convincing therapeutic effects (Huang, L., Fu, C., Xiong, F., He, C. & Wei, Q., 2021). Biomaterials can work as carriers which help deliver nutrient biomolecules to help NSC survive and differentiate to more functional cells or as scaffolds which provide structural bridges to lesion site for NSC migration and tissue regeneration (Vismara, I., Papa, S., Rossi, F., Forloni, G. & Veglianese, P., 2017). In addition, the basic principles of magnetic stimulation and electric stimulation are similar and they all involve producing electrical current on brain or spinal cord to modulate brain or spinal cord activity. It has been revealed that electric stimulation and repetitive magnetic stimulation is associated with neuroplasticity which may reduce inappropriate lateral sprouting resulting from NSC therapy, making them become potential complementary strategies to NSC therapy as well (Kricheldorff, J. et al., 2022).
Suggested Citation
Xinyi Chen, 2023.
"Spinal Cord Injury: Pathophysiology, Neural Stem Cell Treatment and Its Combination with Other Strategies,"
Journal of Innovations in Medical Research, Paradigm Academic Press, vol. 2(8), pages 18-31, August.
Handle:
RePEc:bdz:joimer:v:2:y:2023:i:8:p:18-31
DOI: 10.56397/JIMR/2023.08.04
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bdz:joimer:v:2:y:2023:i:8:p:18-31. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Editorial Office (email available below). General contact details of provider: https://www.paradigmpress.org/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.